194 related articles for article (PubMed ID: 20824477)
1. Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment.
Yan Q
Methods Mol Biol; 2010; 662():285-302. PubMed ID: 20824477
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatics and systems biology methods for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():203-20. PubMed ID: 20824473
[TBL] [Abstract][Full Text] [Related]
3. The role of psychoneuroimmunology in personalized and systems medicine.
Yan Q
Methods Mol Biol; 2012; 934():3-19. PubMed ID: 22933138
[TBL] [Abstract][Full Text] [Related]
4. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
Ludwig S
Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
[TBL] [Abstract][Full Text] [Related]
5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
6. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
7. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
van de Wakker SI; Fischer MJE; Oosting RS
Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
[TBL] [Abstract][Full Text] [Related]
8. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
Yan Q
Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
Vester D; Rapp E; Gade D; Genzel Y; Reichl U
Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
11. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
12. Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Mol Biosyst; 2012 Apr; 8(4):1297-303. PubMed ID: 22307679
[TBL] [Abstract][Full Text] [Related]
13. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
14. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
15. Network based analysis of hepatitis C virus core and NS4B protein interactions.
Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
[TBL] [Abstract][Full Text] [Related]
16. Systems biology and systems genetics - novel innovative approaches to study host-pathogen interactions during influenza infection.
Kollmus H; Wilk E; Schughart K
Curr Opin Virol; 2014 Jun; 6():47-54. PubMed ID: 24769047
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S
Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936
[TBL] [Abstract][Full Text] [Related]
19. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
Yan Q
Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
[TBL] [Abstract][Full Text] [Related]
20. Systems biology as a conceptual framework for research in family medicine; use in predicting response to influenza vaccination.
Majnarić-Trtica L; Vitale B
Prim Health Care Res Dev; 2011 Oct; 12(4):310-21. PubMed ID: 22284946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
